3. Casey, CG, et al. Adverse events associated with smallpox vaccination in the United States, January–October 2003. Journal of the American Medical Association 2005; 294: 2734–2743.
4. Poland, GA, Grabenstein, JD, Neff, JM. The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program. Vaccine 2005; 23: 2078–2081.
5. Kemper, AR, Davis, MM, Freed, GL. Expected adverse events in a mass smallpox vaccination campaign. Effective Clinical Practice 2002; 5: 98–99.
6. Lane, JM, Goldstein, J. Evaluation of 21st-century risks of smallpox vaccination and policy options. Annals of Internal Medicine 2003; 138: 488–493.
7. Conybeare, E. Illness attributed to smallpox vaccination during 1951–60. Monthly Bulletin of the Ministry of Health Laboratory Service 1964; 23: 126–133. 150–159.
8. Dick, G. Smallpox: a reconsideration of public health policies. Progress in Medical Virology 1966; 8: 1–29.
9. Dick, G. Complications of smallpox vaccination in the United Kingdom. International Symposium on Smallpox Vaccine, Bilthoven 1972; Symposia Series in Immunobiological Standardization 1973; 19: 205–215.
10. Martin-Bouyer, C, et al. Deaths due to smallpox vaccination in France, 1968–1977 [in French]. Archives Françaises de Pédiatrie 1980; 37: 199–206.
11. Kretzschmar, M, et al. Frequency of adverse events after vaccination with different vaccinia strains. PLoS Medicine 2006; 3: e272.
12. Lane, J, et al. Complications of smallpox vaccination, 1968. National surveillance in the United States. New England Journal of Medicine 1969; 281: 1201–1208.
13. Lane, J, et al. Complications of smallpox vaccination, 1968. Results of ten statewide surveys. Journal of Infectious Diseases 1970; 122: 303–309.
14. Kerrod, E, et al. Surveillance and control measures during smallpox outbreaks. Emerging Infectious Diseases 2005; 11: 291–297.
15. Riley, S, Ferguson, NM. Smallpox transmission and control: spatial dynamics in Great Britain. Proceedings of the National Academy of Sciences USA 2006; 103: 12637–12642.
16. World Health Organization. Cardiac adverse events following smallpox vaccination – United States 2003. Morbidity and Mortality Weekly Report 2003; 52: 248–250.
17. Fenner, F, et al. Smallpox and its Eradication. Geneva, Switzerland: World Health Organization, 1988.
18. Ström, J, Zetterberg, B. Smallpox outbreak and vaccination problems in Stockholm, Sweden 1963. Acta Medica Scandinavica, Supplementum 1966; 464: 1–171.
19. Kretzschmar, M, et al. Ring vaccination and smallpox control. Emerging Infectious Diseases 2004; 10: 832–841.
20. Keeling, MJ, Bjornstad, ON, Grenfell, BT. Metapopulation dynamics of infectious diseases. In: Hanski, I, Gaggiotti, O eds. Ecology, Genetics, and Evolution of Metapopulations. San Diego: Elsevier, 2004, pp. 415–445.
21. Gani, R, Leach, S. Transmission potential of smallpox in contemporary populations. Nature 2001; 414: 748–751.
22. Mack, T. Smallpox in Europe, 1950–1971. Journal of Infectious Diseases 1972; 125: 161–169.
23. Eichner, M, Dietz, K. Transmission potential of smallpox: estimates based on detailed data from an outbreak. American Journal of Epidemiology 2003; 158: 110–117.
24. Koplan, J, Azizullah, M, Foster, S. Urban hospital and rural village smallpox in Bangladesh. Tropical Geographical Medicine 1978; 30: 355–358.
25. Fraser, C, et al. Factors that make an infectious disease outbreak controllable. Proceedings of the National Academy of Sciences USA 2003; 101: 6146–6151.
26. Wehrle, P, et al. An airborne outbreak of smallpox in a german hospital and its significance with respect to other recent outbreaks in Europe. Bulletin of the World Health Organization 1970; 43: 669–679.
27. Hammarlund, E, et al. Duration of antiviral immunity after smallpox vaccination. Nature Medicine 2003; 9: 1115–1116.
28. Nishiura, H, Schwehm, M, Eichner, M. Still protected against smallpox?: estimation of the duration of vaccine-induced immunity against smallpox. Epidemiology 2006; 17: 576–581.
29. Bozzette, SA, et al. A model for a smallpox-vaccination policy. New England Journal of Medicine 2003; 348: 416–425.
30. Halloran, ME, et al. Containing bioterrorist smallpox. Science 2002; 298: 1428–1432.
31. Kaplan, EH, Craft, DL, Wein, LM. Emergency response to a smallpox attack: the case for mass vaccination. Proceedings of the National Academy of Sciences USA 2002; 99: 10935–10940.
32. Ferguson, NM, et al. Planning for smallpox outbreaks. Nature 2003; 425: 681–685.
33. Eichner, M. Case isolation and contact tracing can prevent the spread of smallpox. American Journal of Epidemiology 2003; 158: 118–128.